Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease-time for action!

Aliment Pharmacol Ther. 2023 May;57(10):1170-1171. doi: 10.1111/apt.17467.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Diabetes Mellitus, Type 2*
  • Heart Disease Risk Factors
  • Humans
  • Liver
  • Non-alcoholic Fatty Liver Disease*
  • Risk Factors